Tumor models are essential in the drug discovery process. They are used to screen potential anti-cancer compounds, study their mechanisms of action, and evaluate their efficacy and toxicity. High-throughput screening in in vitro models can identify promising drug candidates, which are then tested in in vivo models to assess their therapeutic potential. Ultimately, these models help prioritize compounds for clinical trials.
